Compass Therapeutics (CMPX) Other Working Capital Changes (2019 - 2026)

Compass Therapeutics has reported Other Working Capital Changes for 6 years, with the latest figure at -$38000.0 in Q1 2026.

• Quarterly Other Working Capital Changes rose 84.98% year-over-year to -$38000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$154000.0 (up 86.61% YoY) and the FY2025 annual result came in at -$369000.0, up 69.68% from the prior year.
• Other Working Capital Changes was little changed at -$38000.0 in Q1 2026 per CMPX's latest filing, from -$38000.0 in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $6.2 million in Q4 2022 and troughed at -$6.3 million in Q2 2025.
• A 5-year average of -$79000.0 and a median of -$312000.0 in 2025 frame the typical range for Other Working Capital Changes.
• The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes surged 101.66% in 2024, then plunged 840.0% in 2025.
• Over 5 years, Other Working Capital Changes stood at -$284000.0 in 2022, then dropped by 9.15% to -$310000.0 in 2023, then slumped by 86.13% to -$577000.0 in 2024, then soared by 93.41% to -$38000.0 in 2025, then changed by 0.0% to -$38000.0 in 2026.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered -$38000.0, -$38000.0, and -$37000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.